Literature DB >> 32476807

Etiology, Pathology, and Classification of Atrial Fibrillation.

Srishti Nayak1, Balaji Natarajan2, Ramdas G Pai2.   

Abstract

Atrial fibrillation (AF) is a disorganized tachyarrhythmia with significant public health importance due to high morbidity, mortality, and health-care costs. Incidence rate of AF is on the rise and there are several modifiable and nonmodifiable risk factors that are responsible. Exact mechanisms and pathogenesis of AF are still poorly understood, yet they still have great implications in management. The aim of this article is to summarize the epidemiology, major risk factors, and their role in the pathogenesis of AF. Finally, we have reviewed the classification of AF as per professional society guidelines. © Thieme Medical Publishers.

Entities:  

Keywords:  ablation; atrial fibrillation; classification; etiology; pathology; risk factors; stroke

Year:  2020        PMID: 32476807      PMCID: PMC7250635          DOI: 10.1055/s-0040-1705153

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  47 in total

Review 1.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

Review 2.  Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.

Authors:  Jared D Miller; Konstantinos N Aronis; Jonathan Chrispin; Kaustubha D Patil; Joseph E Marine; Seth S Martin; Michael J Blaha; Roger S Blumenthal; Hugh Calkins
Journal:  J Am Coll Cardiol       Date:  2015-12-29       Impact factor: 24.094

Review 3.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

4.  Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.

Authors:  Barak Zafrir; Lars H Lund; Cecile Laroche; Frank Ruschitzka; Maria G Crespo-Leiro; Andrew J S Coats; Stefan D Anker; Gerasimos Filippatos; Petar M Seferovic; Aldo P Maggioni; Manuel De Mora Martin; Lech Polonski; José Silva-Cardoso; Offer Amir
Journal:  Eur Heart J       Date:  2018-12-21       Impact factor: 29.983

Review 5.  Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation.

Authors:  Pasquale Santangeli; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2017-03-02       Impact factor: 6.343

6.  Risk of atrial fibrillation in dipper and nondipper sustained hypertensive patients.

Authors:  Sante D Pierdomenico; Domenico Lapenna; Franco Cuccurullo
Journal:  Blood Press Monit       Date:  2008-08       Impact factor: 1.444

7.  Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

Authors:  Justin B Echouffo-Tcheugui; Peter Shrader; Laine Thomas; Bernard J Gersh; Peter R Kowey; Kenneth W Mahaffey; Daniel E Singer; Elaine M Hylek; Alan S Go; Eric D Peterson; Jonathan P Piccini; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2017-09-12       Impact factor: 24.094

Review 8.  Hypertension and Atrial Fibrillation: Doubts and Certainties From Basic and Clinical Studies.

Authors:  Paolo Verdecchia; Fabio Angeli; Gianpaolo Reboldi
Journal:  Circ Res       Date:  2018-01-19       Impact factor: 17.367

9.  Arrhythmogenic evidence for epicardial adipose tissue: heart rate variability and turbulence are influenced by epicardial fat thickness.

Authors:  Akif Serhat Balcioğlu; Davran Çiçek; Sinan Akinci; Halil Olcay Eldem; Uğur Abbas Bal; Kaan Okyay; Haldun Müderrisoğlu
Journal:  Pacing Clin Electrophysiol       Date:  2014-09-16       Impact factor: 1.976

10.  Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study.

Authors:  Alvaro Alonso; Xiaoyan Yin; Nicholas S Roetker; Jared W Magnani; Richard A Kronmal; Patrick T Ellinor; Lin Y Chen; Steven A Lubitz; Robyn L McClelland; David D McManus; Elsayed Z Soliman; Rachel R Huxley; Saman Nazarian; Moyses Szklo; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2014-10-07       Impact factor: 5.501

View more
  1 in total

1.  Relationship between Serum miR-106 and MYL4 Levels and the Prevalence, Risk Stratification, and Prognosis of Atrial Fibrillation.

Authors:  Yanfeng Liu; Haiwen Zhou; Yu Tao; Zhicheng Xu; Hengli Lai
Journal:  J Immunol Res       Date:  2022-07-14       Impact factor: 4.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.